Tapentadol is partly metabolized via the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medication that increase or repress the action/expression of a number of of those enzymes, and with substrates of such enzymes (because of Competitiveness for that enzyme); some enzyme mediators/substrates involve dosing changes https://buytapentadol100mg91233.webbuzzfeed.com/39855165/rumored-buzz-on-tapentadol-100mg-aspadol